OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
Sabrina Blondy, Valentin David, Mireille Verdier, et al.
Cancer Science (2020) Vol. 111, Iss. 9, pp. 3142-3154
Open Access | Times Cited: 378

Showing 1-25 of 378 citing articles:

Novel therapeutic strategies: targeting epithelial–mesenchymal transition in colorectal cancer
Nan Zhang, Aik Seng Ng, Shijie Cai, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 8, pp. e358-e368
Open Access | Times Cited: 242

Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Qianyu Wang, Xiaofei Shen, Gang Chen, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2928-2928
Open Access | Times Cited: 82

Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis
Haili Wu, Jin’e Du, Chenglu Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3544-3544
Open Access | Times Cited: 70

Plant Foods and Their Bioactives as Dietary Enhancers for Colon Cancer Treatment with 5-Fluorouracil
Zhongming Yang, Carlos L. Céspedes, Zhongguo Yang, et al.
Food Reviews International (2025), pp. 1-50
Closed Access | Times Cited: 6

New insights into natural products that target the gut microbiota: Effects on the prevention and treatment of colorectal cancer
Lu Lu, Jiahuan Dong, Yujing Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 61

Targeting the miR-34a/LRPPRC/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancer
Yang Yang, Hongyu Yuan, Lianmei Zhao, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 11, pp. 2177-2189
Open Access | Times Cited: 57

DNA‐Damage‐Response‐Targeting Mitochondria‐Activated Multifunctional Prodrug Strategy for Self‐Defensive Tumor Therapy
Paramesh Jangili, Na Kong, Ji Hyeon Kim, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 16
Closed Access | Times Cited: 47

Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer
Dzohara Murillo, Carmen Huergo, Borja Gallego, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 208-208
Open Access | Times Cited: 39

Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond
Samar Al Bitar, Marwan El‐Sabban, Samer Doughan, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 9, pp. 1395-1426
Open Access | Times Cited: 36

The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis
Shuai Peng, Lei Shen, Xiaoyun Yu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35

Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant
Rossella Salemi, Silvia Vivarelli, Daria Ricci, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 30

Resveratrol as sensitizer in colorectal cancer plasticity
Aranka Brockmueller, Anjana Sajeev, Lenka Koklesová, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 55-85
Open Access | Times Cited: 26

Interaction of 5-Fluorouracil on the Surfaces of Pristine and Functionalized Ca12O12 Nanocages: An Intuition from DFT
Goodness J. Ogunwale, Hitler Louis, Tomsmith O. Unimuke, et al.
ACS Omega (2023) Vol. 8, Iss. 15, pp. 13551-13568
Open Access | Times Cited: 25

c-Fos regulated by TMPO/ERK axis promotes 5-FU resistance via inducing NANOG transcription in colon cancer
Yanping Gui, Xiaoping Qian, Youxiang Ding, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13

Isolation, structural characterization and biological activity evaluation of melanoidins from thermally processed cocoa beans, carob kibbles and acorns as potential cytotoxic agents
Joanna Oracz, Urszula Lewandowska, Katarzyna Owczarek, et al.
Food Chemistry (2024) Vol. 442, pp. 138423-138423
Closed Access | Times Cited: 10

Advancements in 5-fluorouracil-Loaded liposomal nanosystems: A comprehensive review on recent innovations in nanomedicine for cancer therapy
Mohd Shoab Ali, Saurav Kumar Jha, Garima Gupta, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105730-105730
Closed Access | Times Cited: 9

Long non-coding RNAs in drug resistance across the top five cancers: Update on their roles and mechanisms
Yue Shi, Joseph Adu‐Amankwaah, Qizhong Zhao, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27207-e27207
Open Access | Times Cited: 8

Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions
Samantha Sharma, Naresh Singh, Anita Turk, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 13, pp. 1815-1835
Open Access | Times Cited: 8

Flavonoids and Gastric Cancer Therapy: From Signaling Pathway to Therapeutic Significance
Jiaying Cai, Xiyue Tan, Qichao Hu, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 3233-3253
Open Access | Times Cited: 8

Mechanism of Action and Therapeutic Implications of Nrf2/HO-1 in Inflammatory Bowel Disease
Lingling Yuan, Yingyi Wang, Na Li, et al.
Antioxidants (2024) Vol. 13, Iss. 8, pp. 1012-1012
Open Access | Times Cited: 8

Beyond Chemotherapy: Exploring 5-FU Resistance and Stemness in Colorectal Cancer
Urmila Singh, Rekha Rani Kokkanti, Srinivas Patnaik
European Journal of Pharmacology (2025), pp. 177294-177294
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top